As part of a presentation at the recently held 8th International Conference of Clinical Laboratory Automation (the Cherry Blossom Symposium, 11-13 April, Seoul, Korea), invited speaker Dr Rodney Smith Markin discussed NoemaLife's powerful new middleware solution for clinical laboratories - HALIA - and its ability to deliver improved efficiency, compliance and quality control to laboratories.

Dr Rod Markin is an internationally recognised pioneer and leading authority in the field of lab automation. In his role as David T. Purtilo Distinguished Professor of Pathology and Microbiology, Associate Vice Chancellor for Business Development, and Chief Technology Officer at the University of Nebraska Medical Center in Omaha, he looks for new uses for information systems and works closely with different departments to plan major equipment purchases.

In his symposium presentation ‘Past, Present and Future of Laboratory Information', Dr Markin noted the economic factors driving the move towards automation. Growing competition between clinical laboratories for a share of the diagnostics market, budget constraints, and pressure on staff numbers all play a part. He cited HALIA, with its powerful rule-based engine, as meeting the needs of laboratories by supporting open automation systems and offering a multi-lab mode.

Andrea Chiapponi, Managing Director of NoemaLife S.p.A. said, ‘We are delighted that Dr Markin's talk included references to HALIA. This latest middleware solution from NoemaLife allows central management of all analysis instruments, even those located in different laboratories, through a single web-based interface. HALIA's powerful functionality enables labs to enhance their efficiency, compliance and quality control.' 

Held biannually in different countries within Asia, the Cherry Blossom Symposium is one of the most highly acclaimed meetings in the field of laboratory automation.

For more information about NoemaLife click here


About NoemaLife

NoemaLife is a leading provider of clinical and hospital IT Software Solutions, dedicated to the enhancement of workflow automation, cost savings and quality of care at every level of the healthcare delivery process. It has been listed on the Italian Stock Exchange (MTA) since 2006 (NOE-ISIN IT0004014533). 

NoemaLife, which employs a staff of 700 qualified professionals worldwide, has a direct market presence in Italy, Germany, France, United Kingdom, Belgium, Argentina, Chile, Japan and the United Arab Emirates. It also operates in Latin America, Northern Europe and Australia through a distribution network. Thanks to its acquisition in 2011 of a majority stake in the French group Medasys, NoemaLife consolidated its role as leading European vendor of IT solutions for clinical processes.

The NoemaLife Group closed 2011 with consolidated sales of 48.5 million euros (+13% on 2010).